Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< BACK TO CLINICAL BREAKTHROUGHS IN UROLOGY

November 2020

UROLOGY

CASE REPORT: FERTILITY PRESERVATION FOR NEUROSARCOIDOSIS

Featuring: Joshua A. Halpern, MD​
A 39-year-old man presented to the office with a new diagnosis of neurosarcoidosis causing transverse myelitis. He and his wife were actively trying to conceive their second child, but he was experiencing anejaculation. Perhaps even more challenging, he required urgent medical therapy for treatment of his sarcoidosis, which would involve methotrexate, a gonadotoxic and potentially teratogenic drug. They were seeking consultation for fertility preservation before initiation of methotrexate treatment, and time was of the essence.

Initial laboratory evaluation demonstrated low serum testosterone of 185 ng/dL and elevated follicle stimulating hormone (FSH) of 7.6 mIU/mL, indicating that there was potentially an issue with spermatogenesis, yet another obstacle to overcome. He was started on clomiphene citrate, 25mg daily, and multiple attempts were made at cryopreservation with the assistance of PVS. Unfortunately, he remained unable to ejaculate. Working closely with his neurologist, our team agreed to delay the initiation of methotrexate therapy for one week in preparation for surgical sperm extraction.

The patient had a successful microsurgical TESE, yielding 8 vials of cryopreserved samples. The patient was started on methotrexate therapy for his sarcoidosis, and the couple is planning to begin in vitro fertilization (IVF) in the coming months.

This couple demonstrates the importance of fertility preservation, particularly in the setting of benign disease, wherein many patients and physicians are not aware of the gonadotoxic effects of lifesaving medications. Through multidisciplinary cooperation between the Urology and Neurology teams at Northwestern Medicine, we were able 
to help this couple achieve their goal of fertility preservation without compromising treatment for his neurosarcoidosis.

To refer a patient or request a second opinion, call 312.695.8146.
Joshua A. Halpern, MD  Headshot
Joshua A. Halpern, MD Northwestern Medical Group Urology

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​
Call 312.695.8146
Find an NM Urologist

You May Also Like

Headshot of Dr. Krambeck

November 2021

UROLOGY
Urology Practice in the Post-COVID-19 Era: Backlog Management, Shift to Same-Day Discharge, Efficiency Improvement, and More
Picture

October 2021

UROLOGY
Virtual CME Opportunity: Updates and Advances in Urologic Oncology
Video still of Dr. Ashley Ross

October 2021

UROLOGY
Prostate Cancer in Gay and Bisexual Men: Treatment Side Effects and Decision-Making

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties